Moricizine: a new agent for the treatment of ventricular arrhythmias.
 Over the last several years, a number of new antiarrhythmic agents have come into use.
 One of these promising new drugs, moricizine hydrochloride (Ethmozine), is now available for use in this country.
 Although similar in some aspects to both quinidine and lidocaine, Moricizine hydrochloride is in many ways unique.
 The purpose of this review is to summarize the pharmacologic and physiologic effects of moricizine and to outline its clinical use.
